USPTO serial 97087362
LEITERS HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 26, 2024
- Examiner
- MACDOUGALL, KIERRA RYNNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LEITERS HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Englewood, CO
Englewood, CO
Englewood, CO
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet M. Garetto
Janet M. Garetto NIXON PEABODY LLP70 WEST MADISON STREET, SUITE 5200CHICAGO, IL 60602United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Syringes sold filled with medication for treating a wide variety of conditions and illnesses; Intravenous bags sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Vials sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medication reservoirs and cassettes sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time which are sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses | ACTIVE | Nov 15, 2023 |
| 009 | Downloadable electronic publications, namely, brochures, magazines and newsletters in the field of training and/or continuing education for compounding pharmacists | ACTIVE | Dec 1, 2023 |
| 035 | Pharmacy outsourcing services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Central fill pharmacy services | ACTIVE | Jul 24, 2023 |
| 039 | Packaging and repackaging of pharmaceutical products for human use to the order and specification of others | ACTIVE | Jul 24, 2023 |
| 041 | Providing a blog website featuring non-downloadable publications in the nature of brochures, magazines, newsletters and articles regarding training and/or continuing education for compounding pharmacists in the fields of pharmaceuticals and/or pharmaceutical compounding; Non-downloadable electronic publications in the nature of brochures, magazines and newsletters in the field of training and/or continuation education for compounding pharmacists | ACTIVE | Jul 24, 2023 |
| 042 | Development of pharmaceutical preparations and medicines | ACTIVE | Jul 24, 2023 |
| 044 | Pharmaceutical compounding services | ACTIVE | Jul 24, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LEITERS, INC.
- Other trademarks owned by LEITERS, INC.
- Other trademarks owned by LEITERS, INC.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LEITERS HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 1, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 1, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 26, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 26, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 25, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jul 25, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 7, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 5, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 5, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 5, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 25, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 23, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 10, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 9, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 9, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |